InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
4
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-60.2%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Pelletier Saundra l, Chairman & CEO. Insider active across 3 companies, notably Evofem Biosciences, Inc.. Aggregated, 8 disclosures have been published. Breakdown: 4 buys · 0 sell. Total volume traded: €155k. History available since 20 May 2021. The latest transaction was disclosed on 31 December 2022 (Disposition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Pelletier Saundra l
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
50,000 shares0Common StockSEC:0001251371-23-000002:0
141,000 shares@ US$0.35255.38% mcap15.7% of flowCommon StockSEC:0001618835-22-000130:0
Canonical exit: 25 Aug 2022 (T+90)
750,000 shares0Common StockSEC:0001618835-22-000028:0
300,000 shares0Common StockSEC:0001618835-22-000004:0
135,000 shares@ US$0.37521.7% of flowCommon StockSEC:0001618835-21-000271:0
Canonical exit: 20 Mar 2022 (T+90)
6,545 shares@ US$3.82100.0% of flowCommon StockSEC:0001209191-21-048272:0
Canonical exit: 24 Oct 2021 (T+90)
50,000 shares@ US$1.0320.4% of flowCommon StockSEC:0001618835-21-000147:0
Canonical exit: 8 Sept 2021 (T+90)
105,300 shares@ US$0.8635.7% of flowCommon StockSEC:0001618835-21-000133:0
8 of 8 declarations
About Pelletier Saundra l
Saundra L. Pelletier is the Chairman & CEO of Evofem Biosciences, Inc. and Tracon Pharmaceuticals, Inc. She also serves as a Director at these companies. Her responsibilities include strategic and operational leadership, aiming to maximize shareholder value and ensure sustainable growth.
